Apervita, a Chicago, IL-based platform for value-based collaboration in healthcare, secured $22m in funding.
Backers included Optum Ventures, Pritzker Group Venture Capital, Baird Capital, Math Ventures, Levy Family Partners, Illinois Venture and Wintrust.
The company intends to use the funds to to accelerate investment in technology and support expansion in partnership with its client base.
Led by Kevin Hutchinson, CEO, Apervita provides a collaboration platform for value-based healthcare. It empower payers and providers and other stakeholders to measure clinical and financial performance, improve clinical quality and administer value-based contracts. By providing an independent platform to perform shared analyses, the system allows stakeholders to gain mutual, continuous clinical and financial insights and integrate those insights in various systems and workflows simultaneously and at scale.
Today, the platform computes over 10 billion quality computations each year using digital measures such as The Centers for Medicare and Medicaid’s electronic quality measures (eCQMs). Apervita is the first to receive certification from National Committee for Quality Assurance (NCQA) for clinical quality language (CQL) based execution of eCQMs, and is currently among the first companies pursuing certification for digital versions of Electronic Clinical Data Systems (ECDS) and Healthcare Effectiveness Data and Information (HEDIS®) measures released by NCQA.